(Q30357351)

20 June 2017

title

Establishing the health and economic impact of influenza vaccination within the European Union 25 countries. (English)

1 reference

20 June 2017

James Ryan

1

1 reference

20 June 2017

York Zoellner

2

1 reference

20 June 2017

Birgit Gradl

3

1 reference

20 June 2017

Bram Palache

4

1 reference

20 June 2017

Jeroen Medema

5

1 reference

20 June 2017

language of work or name

English

0 references

publication date

4 August 2006

1 reference

20 June 2017

1 reference

20 June 2017

volume

24

1 reference

20 June 2017

issue

47-48

1 reference

20 June 2017

page(s)

6812-6822

1 reference

Health impact of influenza in the United States.

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

The socio-economic burden of influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Mortality associated with influenza and respiratory syncytial virus in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Influenza burden of illness, diagnosis, treatment, and prevention: what is the evidence in children and where are the gaps?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Population-based study on incidence, risk factors, clinical complications and drug utilisation associated with influenza in the United Kingdom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Influenza: prospects for control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

New options for prevention and control of influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

7 January 2021

Influenza vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Economic costs of influenza-related work absenteeism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Influenza vaccination among healthy employees: a cost-benefit analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Economic impact of influenza vaccination in preschool children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Socioeconomic impact of influenza on healthy children and their families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Burden of influenza in children in the community

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Modeling pandemic preparedness scenarios: health economic implications of enhanced pandemic vaccine supply

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

The health and economic benefits of influenza vaccination for healthy and at-risk persons aged 65 to 74 years

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Influenza vaccination, hospitalizations, and costs among members of a Medicare managed care plan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Economic evaluation of vaccination against influenza in the elderly: an experience from a population-based influenza vaccination program in Taiwan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Economic evaluation of strategies for the control and management of influenza in Europe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

An economic analysis of annual influenza vaccination of children.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Immune response to influenza vaccination of elderly people. A randomized double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

Effectiveness of influenza vaccine in the elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2006.07.042

10.1016/J.VACCINE.2006.07.042

7 January 2021

Identifiers

DOI

1 reference

20 June 2017

1 reference